STU:TED has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STU:TED has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
TerrAscend Corp STU:TED
TerrAscend STU:TED +3.15% 38 Tariff Resilience Score is 7 as of Jun. 25, 2026. GuruFocus rates STU:TED with a GF Score™ of 38/100 and a GF Value™ of €0.85 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,031 Drug Manufacturers companies, TerrAscend ranks better than 97.09% on this metric.
TerrAscend has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.
TerrAscend has TerrAscend operates primarily in North America, reducing exposure to international tariffs. The cannabis industry faces regulatory challenges but is less impacted by traditional trade tariffs. Domestic focus and market growth provide resilience.
Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.
The company's exposure to international trade tariffs based on these criteria:
1. Global supply chain dependenciesBased on the research, GuruFocus believes TerrAscend might have Highly Resilient.
TerrAscend (STU:TED) Tariff Resilience Score Explanation
The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:
| Tariff Resilience Score | Resilience Level |
| 7 - 10 | Highly Resilient |
| 4 - 6 | Average Resilient |
| 0 - 3 | Highly Vulnerable |
For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, TerrAscend's Tariff Resilience Score distribution charts can be found below:
* The bar in red indicates where TerrAscend's Tariff Resilience Score falls into.
Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued. The current stock price of €0.56 is trading 34.5% below its estimated GF Value™ of €0.85. GuruFocus considers TerrAscend to be Possible Value Trap.
Key valuation signals for STU:TED:
No single metric tells the full story. See the STU:TED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.